Activity value 76united states Buyer&Supplier,Last transaction date:
2026-02-28Address: 1420 century dr.suite 1300 carrolit on, united states
Overview
Export data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for agrace pharma from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 74 transactions, with a transaction quantity of 739 and a transaction weight of 0.
Product description
LOSARTAN POTASSIUM ORAL SUSPENSION 10MG ML ARBLI TL NO SW ND CT 17 2026 0000014996 FOR R&D PURPOSE NOT FOR SALELOSARTAN POTASSIUM ORAL SUSPENSION 10MG ML ARBLI TL NO S
Expand
Hs code
30049099
Product tags
for injection,vial,indocyanine green,ale
Product description
INDOCYANINE GREEN FOR INJECTION USP 25 MG VIAL TL NO SW ND CT 17 2024 000005946 QTY 6INJ FOR R&D PURPOSE NOT FOR SALEINDOCYANINE GREEN FOR INJECTION USP 25 MG VIAL TL NO SW ND
Expand
agrace pharma is united states Buyer&Supplier,
and primarily engages in the import and export business of products such as tablet,injection,ting.
According to the 52wmb.com global trade database, as of 2026-02-28, the company has completed 2178 international trades,
with its main trading regions covering india,yemen,other etc.
The core products include HS30049099,HS98020000,HS90183990 etc,
often transported via dallas,port new york, port miami etc,
and its main trading partners are dr reddy s laborotoies inc.,hetero labs ltd.,aurobindo pharama ltd..
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on agrace pharma is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.